Albemarle Corporation  

(Public, NYSE:ALB)   Watch this stock  
Find more results for ALB
69.07
+1.53 (2.27%)
After Hours: 69.07 0.00 (0.00%)
Jul 25, 4:43PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 67.58 - 69.17
52 week 60.89 - 76.28
Open 67.58
Vol / Avg. 1.93M/1.17M
Mkt cap 5.49B
P/E 14.70
Div/yield 0.28/1.59
EPS 4.70
Shares 79.55M
Beta 1.62
Inst. own 81%
Jul 31, 2014
Q2 2014 Albemarle Corporation Earnings Call - 9:00AM EDT - Add to calendar
Jul 30, 2014
Q2 2014 Albemarle Corporation Earnings Release - 4:00PM EDT - Add to calendar
Jun 19, 2014
Albemarle Corp at Goldman Sachs European Chemicals 2020 Vision Conference - Webcast
Jun 4, 2014
Albemarle Corporation at J.P. Morgan's Global Leaders 1x1 Forum
May 15, 2014
Albemarle Corporation 2014 Investor Day
May 13, 2014
Albemarle Corporation Annual Meeting of Shareholders
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 8.43% 15.60%
Operating margin 11.48% 22.28%
EBITD margin - 27.66%
Return on average assets 6.21% 11.62%
Return on average equity 14.04% 23.88%
Employees 4,231 -
CDP Score - -

Address

451 FLORIDA STREET
BATON ROUGE, LA 70801
United States - Map
+1-225-3887402 (Phone)
+1-225-3887686 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Albemarle Corporation (Albemarle) is a developer, manufacturer and marketer of specialty chemicals, which meet customer needs across a range of end markets, including the petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food-safety and custom chemistry services markets. As of December 31, 2011, the Company and its joint ventures operated 50 facilities, encompassing production, research and development facilities, and administrative and sales offices in North and South America, Europe, the Middle East, Asia, Africa and Australia. It serves approximately 3,000 customers in over 100 countries. It operates in three segments: Polymer Solutions, Catalysts and Fine Chemistry. On May 11, 2011, the Company acquired Catilin Inc. In October 2013, Albemarle Corp acquired Cambridge Chemical Co Ltd.

Officers and directors

Luther C. Kissam IV President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Scott A. Tozier Chief Financial Officer, Senior Vice President, Chief Risk Officer
Age: 48
Bio & Compensation  - Reuters
Karen G. Narwold Senior Vice President, General Counsel, Corporate Secretary, Corporate and Government Affairs
Age: 54
Bio & Compensation  - Reuters
Susan M. Kelliher Senior Vice President - Human Resources
Age: 47
Bio & Compensation  - Reuters
Matthew K. Juneau Senior Vice President, President - Performance Chemicals
Age: 53
Bio & Compensation  - Reuters
D. Michael Wilson Senior Vice President, President - Catalyst Solutions
Age: 51
Bio & Compensation  - Reuters
Ronald C. Zumstein Senior Vice President - Manufacturing, Supply Chain and Process Excellence
Age: 52
Bio & Compensation  - Reuters
Donald J. LaBauve Jr. Chief Accounting Officer, Vice President, Corporate Controller
Age: 47
Bio & Compensation  - Reuters
Scott A. Martin Vice President - Fine Chemistry
Age: 55
Bio & Compensation  - Reuters
James W. Nokes Independent Non-Executive Chairman of the Board
Age: 67
Bio & Compensation  - Reuters